Induced pluripotent stem cells from human placental chorion for perinatal tissue engineering applications

Tissue Engineering - Part C: Methods

Volumn 20, Issue 9, 2014, Pages 731-740

  Jiang, Guihua ^a   Di Bernardo, Julie ^a   Delong, Cynthia J ^a   Monteiro Da Rocha, André ^a   O'Shea, K Sue ^a   Kunisaki, Shaun M ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; GENE EXPRESSION; STEM CELLS; TISSUE; TISSUE ENGINEERING;

DERMAL FIBROBLASTS; ECTOPIC EXPRESSIONS; GENE EXPRESSION STUDIES; IMMUNOCYTOCHEMISTRY; INDUCED PLURIPOTENT STEM CELLS; MESENCHYMAL STROMAL CELLS; NEURAL STEM CELL; TISSUE ENGINEERING APPLICATIONS;

CELL ENGINEERING;

KRUPPEL LIKE FACTOR 4; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX2;

ARTICLE; CELL DIFFERENTIATION; CELL STRUCTURE; CHORION; CONTROLLED STUDY; EMBRYOID BODY; EMBRYONAL TISSUE; FEMALE; FIBROBLAST; FLOW CYTOMETRY; GENE EXPRESSION; GERM LAYER; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOPHENOTYPING; IN VITRO STUDY; MESENCHYMAL STROMA CELL; NEURAL STEM CELL; ONTOGENY; PERINATAL CARE; PLURIPOTENT STEM CELL; PREGNANCY; PROTEIN EXPRESSION; SOMATIC CELL; TISSUE ENGINEERING; UMBILICAL CORD BLOOD; UPREGULATION; CELL LINEAGE; CYTOLOGY; ENDODERM; PLACENTA; PROCEDURES;

CELL DIFFERENTIATION; CELL LINEAGE; CHORION; EMBRYOID BODIES; ENDODERM; FEMALE; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MESENCHYMAL STROMAL CELLS; MYOCYTES, CARDIAC; PLACENTA; PREGNANCY; TISSUE ENGINEERING;

EID: 84906968052     PISSN: 19373384     EISSN: 19373392     Source Type: Journal    
DOI: 10.1089/ten.tec.2013.0480     Document Type: Article

References (35)

1. Takahashi, K., and Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663, 2006.
2. Yu, J., Vodyanik, M.A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J.L., Tian, S., Nie, J., Jonsdottir, G.A., Ruotti, V., Stewart, R., Slukvin, II, and Thomson, J.A. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917, 2007.
3. Park, I.H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M.W., Cowan, C., Hochedlinger, K., and Daley, G.Q. Disease-specific induced pluripotent stem cells. Cell 134, 877, 2008.
4. Sun, N., Panetta, N.J., Gupta, D.M., Wilson, K.D., Lee, A., Jia, F., Hu, S., Cherry, A.M., Robbins, R.C., Longaker, M.T., and Wu, J.C. Feeder-free derivation of induced plu-ripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci USA 106, 15720, 2009.
5. Giorgetti, A., Montserrat, N., Aasen, T., Gonzalez, F., Rodriguez-Piza, I., Vassena, R., Raya, A., Boue, S., Bar-rero, M.J., Corbella, B.A., Torrabadella, M., Veiga, A., and Izpisua Belmonte, J.C. Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell 5, 353, 2009.
6. Jones, G.N., Moschidou, D., Puga-Iglesias, T.I., Kulesze-wicz, K., Vanleene, M., Shefelbine, S.J., Bou-Gharios, G., Fisk, N.M., David, A.L., De Coppi, P., and Guillot, P.V. Ontological differences in first compared to third trimester human fetal placental chorionic stem cells. PLoS One 7, e43395, 2012.
7. Cai, J., Li, W., Su, H., Qin, D., Yang, J., Zhu, F., Xu, J., He, W., Guo, X., Labuda, K., Peterbauer, A., Wolbank, S., Zhong, M., Li, Z., Wu, W., So, K.F., Redl, H., Zeng, L., Esteban, M.A., and Pei, D. Generation of human induced pluripotent stem cells from umbilical cord matrix and amniotic membrane mesenchymal cells. J Biol Chem 285, 11227, 2010.
8. Fujioka, T., Shimizu, N., Yoshino, K., Miyoshi, H., and Nakamura, Y. Establishment of induced pluripotent stem cells from human neonatal tissues. Hum Cell 23, 113, 2010.
9. Nazarov, I., Lee, J.W., Soupene, E., Etemad, S., Knapik, D., Green, W., Bashkirova, E., Fang, X., Matthay, M.A., Kuypers, F.A., and Serikov, V.B. Multipotent stromal stem cells from human placenta demonstrate high therapeutic potential. Stem Cells Transl Med 1, 359, 2012.
10. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., Deans, R., Keating, A., Prockop, D., and Horwitz, E. Minimal criteria for defining multipotent mesen-chymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315, 2006.
11. Villa-Diaz, L.G., Brown, S.E., Liu, Y., Ross, A.M., Lahann, J., Parent, J.M., and Krebsbach, P.H. Derivation of mesenchymal stem cells from human induced pluripotent stem cells cultured on synthetic substrates. Stem Cells 30, 1174, 2012.
12. Bentley, J.K., Popova, A.P., Bozyk, P.D., Linn, M.J., Baek, A.E., Lei, J., Goldsmith, A.M., and Hershenson, M.B. Ovalbumin sensitization and challenge increases the number of lung cells possessing a mesenchymal stromal cell phenotype. Respir Res 11, 127, 2010.
13. Park, I.H., and Daley, G.Q. Human iPS cell derivation/reprogramming. Curr Protoc Stem Cell Biol Chapter 4, Unit 4A.1, 2009.
14. Itskovitz-Eldor, J., Schuldiner, M., Karsenti, D., Eden, A., Yanuka, O., Amit, M., Soreq, H., and Benvenisty, N. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med 6, 88, 2000.
15. Livak, K.J., and Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402, 2001.
16. Mak, S.K., Huang, Y.A., Iranmanesh, S., Vangipuram, M., Sundararajan, R., Nguyen, L., Langston, J.W., and Schule, B. Small molecules greatly improve conversion of human-induced pluripotent stem cells to the neuronal lineage. Stem Cells Int 2012, 140427, 2012.
17. Zhang, J., Klos, M., Wilson, G.F., Herman, A.M., Lian, X., Raval, K.K., Barron, M.R., Hou, L., Soerens, A.G., Yu, J., Palecek, S.P., Lyons, G.E., Thomson, J.A., Herron, T.J., Jalife, J., and Kamp, T.J. Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: the matrix sandwich method. Circ Res 111, 1125, 2012.
18. D'Amour, K.A., Agulnick, A.D., Eliazer, S., Kelly, O.G., Kroon, E., and Baetge, E.E. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol 23, 1534, 2005.
19. Spence, J.R., Mayhew, C.N., Rankin, S.A., Kuhar, M.F., Vallance, J.E., Tolle, K., Hoskins, E.E., Kalinichenko, V.V., Wells, S.I., Zorn, A.M., Shroyer, N.F., and Wells, J.M. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 470, 105, 2011.
20. Esteban, M.A., Wang, T., Qin, B., Yang, J., Qin, D., Cai, J., Li, W., Weng, Z., Chen, J., Ni, S., Chen, K., Li, Y., Liu, X., Xu, J., Zhang, S., Li, F., He, W., Labuda, K., Song, Y., Peterbauer, A., Wolbank, S., Redl, H., Zhong, M., Cai, D., Zeng, L., and Pei, D. Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 6, 71, 2010.
21. Parolini, O., Alviano, F., Bagnara, G.P., Bilic, G., Buhring, H.J., Evangelista, M., Hennerbichler, S., Liu, B., Magatti, M., Mao, N., Miki, T., Marongiu, F., Nakajima, H., Ni-kaido, T., Portmann-Lanz, C.B., Sankar, V., Soncini, M., Stadler, G., Surbek, D., Takahashi, T.A., Redl, H., Sakur-agawa, N., Wolbank, S., Zeisberger, S., Zisch, A., and Strom, S.C. Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells 26, 300, 2008.
22. Prasongchean, W., Bagni, M., Calzarossa, C., De Coppi, P., and Ferretti, P. Amniotic fluid stem cells increase embryo survival following injury. Stem Cells Dev 21, 675, 2012.
23. Macias, M.I., Grande, J., Moreno, A., Dominguez, I., Bornstein, R., and Flores, A.I. Isolation and characterization of true mesenchymal stem cells derived from human term decidua capable of multilineage differentiation into all 3 embryonic layers. Am J Obstet Gynecol 203, 495 e9, 2010.
24. Ye, L., Chang, J.C., Lin, C., Sun, X., Yu, J., and Kan, Y.W. Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases. Proc Natl Acad Sci USA 106, 9826, 2009.
25. Li, C., Zhou, J., Shi, G., Ma, Y., Yang, Y., Gu, J., Yu, H., Jin, S., Wei, Z., Chen, F., and Jin, Y. Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells. Hum Mol Genet 18, 4340, 2009.
26. Galende, E., Karakikes, I., Edelmann, L., Desnick, R.J., Kerenyi, T., Khoueiry, G., Lafferty, J., McGinn, J.T., Brod-man, M., Fuster, V., Hajjar, R.J., and Polgar, K. Amniotic fluid cells are more efficiently reprogrammedtopluripotency than adult cells. Cell Reprogram 12, 117, 2010.
27. Zhao, H.X., Li, Y., Jin, H.F., Xie, L., Liu, C., Jiang, F., Luo, Y.N., Yin, G.W., Wang, J., Li, L.S., Yao, Y.Q., and Wang, X.H. Rapid and efficient reprogramming of human amnion-derived cells into pluripotency by three factors OCT4/SOX2/NANOG. Differentiation 80, 123, 2010.
28. Liu, P., Chen, S., Li, X., Qin, L., Huang, K., Wang, L., Huang, W., Li, S., Jia, B., Zhong, M., Pan, G., Cai, J., and Pei, D.Low immunogenicity of neural progenitor cells differentiated from induced pluripotent stem cells derived from less im-munogenic somatic cells. PLoS One 8, e69617, 2013.
29. Bieback, K., and Brinkmann, I. Mesenchymal stromal cells from human perinatal tissues: from biology to cell therapy. World J Stem Cells 2, 81, 2010.
30. Kern, S., Eichler, H., Stoeve, J., Kluter, H., and Bieback, K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24, 1294, 2006.
31. Loh, Y.H., Hartung, O., Li, H., Guo, C., Sahalie, J.M., Manos, P.D., Urbach, A., Heffner, G.C., Grskovic, M., Vigneault, F., Lensch, M.W., Park, I.H., Agarwal, S., Church, G.M., Collins, J.J., Irion, S., and Daley, G.Q. Re-programming of T cells from human peripheral blood. Cell Stem Cell 7, 15, 2010.
32. Kim, K., Zhao, R., Doi, A., Ng, K., Unternaehrer, J., Cahan, P., Huo, H., Loh, Y.H., Aryee, M.J., Lensch, M.W., Li, H., Collins, J.J., Feinberg, A.P., and Daley, G.Q. Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Nat Bio-technol 29, 1117, 2011.
33. Fauza, D. Amniotic fluid and placental stem cells. Best Pract Res Clin Obstet Gynaecol 18, 877, 2004.
34. Titomanlio, L., Kavelaars, A., Dalous, J., Mani, S., El Ghouzzi, V., Heijnen, C., Baud, O., and Gressens, P. Stem cell therapy for neonatal brain injury: perspectives and challenges. Ann Neurol 70, 698, 2011.
35. Bailo, M., Soncini, M., Vertua, E., Signoroni, P.B., San-zone, S., Lombardi, G., Arienti, D., Calamani, F., Zatti, D., Paul, P., Albertini, A., Zorzi, F., Cavagnini, A., Candotti, F., Wengler, G.S., and Parolini, O. Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation 78, 1439, 2004.